JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB214549

Anti-Nanog antibody [EPR20694] - ChIP Grade

  • RabMAb
  • Advanced Validation
  • Recombinant
  • 20ul selling size
  • What is this?

5

(3 Reviews)

|

(17 Publications)

Rabbit Recombinant Monoclonal NANOG antibody. Suitable for ChIC/CUT&RUN-seq, IP, ChIP, WB, ICC/IF, Flow Cyt (Intra), IHC-P and reacts with Mouse samples. Cited in 17 publications.

View Alternative Names

Ecat4, Enk, Nanog, Homeobox protein NANOG, ES cell-associated protein 4, Early embryo specific expression NK-type homeobox protein, Homeobox transcription factor Nanog

9 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Nanog antibody [EPR20694] - ChIP Grade (AB214549)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Nanog antibody [EPR20694] - ChIP Grade (AB214549)

Immunohistochemical analysis of paraffin-embedded adult mouse testis tissue labeling Nanog with ab214549 at 1/500 dilution, followed by Goat Anti-Rabbit IgG H&L (HRP) Ready to use. Negative tissue : No staining on adult mouse testis is observed(PMID : 12787505; PMID : 15939376).

Counter stained with Hematoxylin.

Heat mediated antigen retrieval was performed with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.

Flow Cytometry (Intracellular) - Anti-Nanog antibody [EPR20694] - ChIP Grade (AB214549)
  • Flow Cyt (Intra)

Supplier Data

Flow Cytometry (Intracellular) - Anti-Nanog antibody [EPR20694] - ChIP Grade (AB214549)

Intracellular flow cytometric analysis of 4 % paraformaldehyde-fixed, 90% methanol permeabilized F9 (mouse embryonic testicular cancer cell line, Right) and NIH/3T3 (mouse embryo fibroblast cell line, Left) cells labeling Nanog with ab214549 at 1/60 dilution (red) compared with a Rabbit IgG, monoclonal [EPR25A] - Isotype Control (ab172730) (black) and an unlabeled control (cells without incubation with primary antibody and secondary antibody) (blue). Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) (ab150077) at 1/2000 dilution was used as the secondary antibody.

Negative control : NIH/3T3 cell line.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Nanog antibody [EPR20694] - ChIP Grade (AB214549)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Nanog antibody [EPR20694] - ChIP Grade (AB214549)

Immunohistochemical analysis of paraffin-embedded mouse E14.5 testis tissue labeling Nanog with ab214549 at 1/500 dilution, followed by Goat Anti-Rabbit IgG H&L (HRP) Ready to use. Mainly nuclear staining is observed in testis of mouse embryo E14.5 (PMID : 15939376; PMID : 12787505). Counter stained with Hematoxylin.

Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) Ready to use.

Heat mediated antigen retrieval was performed with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.

Immunocytochemistry/ Immunofluorescence - Anti-Nanog antibody [EPR20694] - ChIP Grade (AB214549)
  • ICC/IF

Supplier Data

Immunocytochemistry/ Immunofluorescence - Anti-Nanog antibody [EPR20694] - ChIP Grade (AB214549)

Immunofluorescent analysis of 4% paraformaldehyde-fixed, 0.1% Triton X-100 permeablized F9 (mouse embryonic testicular cancer cell line) and NIH/3T3 (mouse embryo fibroblast cell line) cells labeling Nanog with ab214549 at 1/100 dilution, followed by Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) (ab150077) secondary antibody at 1/1000 dilution (green). Confocal image showing nuclear staining in F9 cell line. Negative control : NIH/3T3 (PMID : 17352742).

The nuclear counter stain is DAPI (blue). Tubulin is detected with Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594) (ab195889) (red) at 1/200 dilution.

Control : Used PBS instead of primary antibody, secondary antibody is Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) (ab150077) secondary antibody at 1/1000 dilution.

Immunoprecipitation - Anti-Nanog antibody [EPR20694] - ChIP Grade (AB214549)
  • IP

Supplier Data

Immunoprecipitation - Anti-Nanog antibody [EPR20694] - ChIP Grade (AB214549)

Nanog was immunoprecipitated from 0.35 mg of F9 (mouse embryonic testicular cancer cell line) whole cell lysate with ab214549 at 1/1000 dilution. Western blot was performed from the immunoprecipitate using ab214549 at 1/1000 dilution. VeriBlot for IP Detection Reagent (HRP) (ab131366), was used for detection at 1/5,000 dilution

Lane 1 : F9 whole cell lysate 10 μg (input)

Lane 2 : ab214549 IP in F9 whole cell lysate.

Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab214549 in F9 whole cell lysate.

Blocking and dilution buffer and concentration : 5% NFDM/TBST.

Exposure time : 15 seconds.

The multiple bands observed are consistent with the literature (PMID : 24936455).

All lanes:

Immunoprecipitation - Anti-Nanog antibody [EPR20694] - ChIP Grade (ab214549)

Predicted band size: 34 kDa

false

ChIP - Anti-Nanog antibody [EPR20694] - ChIP Grade (AB214549)
  • ChIP

Unknown

ChIP - Anti-Nanog antibody [EPR20694] - ChIP Grade (AB214549)

Chromatin was prepared from F9 cells according to the Abcam X-ChIP protocol. Cells were fixed with 1% formaldehyde for 10 minutes. The ChIP was performed with 25 μg of chromatin, 5μg of ab214549 (red), and 20 μl of protein A/G sepharose beads slurry (10 μl of sepharose A beads + 10 μl of sepharose G beads). Then 5 μg of rabbit normal IgG was added to the control beads (grey). The immunoprecipitated DNA was quantified by real time PCR (SYBR green chemistry).

Western blot - Anti-Nanog antibody [EPR20694] - ChIP Grade (AB214549)
  • WB

Supplier Data

Western blot - Anti-Nanog antibody [EPR20694] - ChIP Grade (AB214549)

Blocking/Dilution buffer : 5% NFDM/TBST.

The multiple bands observed are consistent with the literature (PMID : 24936455).

All lanes:

Western blot - Anti-Nanog antibody [EPR20694] - ChIP Grade (ab214549) at 1/1000 dilution

All lanes:

ES-D3 (mouse embryonic multipotent stem cell line) whole cell lysate at 10 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution

Predicted band size: 34 kDa

Observed band size: 29-42 kDa

true

Exposure time: 3min

Western blot - Anti-Nanog antibody [EPR20694] - ChIP Grade (AB214549)
  • WB

Supplier Data

Western blot - Anti-Nanog antibody [EPR20694] - ChIP Grade (AB214549)

Blocking/Dilution buffer : 5% NFDM/TBST.

The multiple bands observed are consistent with the literature (PMID : 24936455). Negative control : NIH/3T3 (PMID : 12787505).

All lanes:

Western blot - Anti-Nanog antibody [EPR20694] - ChIP Grade (ab214549) at 1/1000 dilution

Lane 1:

F9 (Mouse embryonic testicular cancer cell line) whole cell lysate at 20 µg

Lane 2:

NIH/3T3 (mouse embryo fibroblast cell line) whole cell lysate at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution

Predicted band size: 34 kDa

Observed band size: 29-42 kDa

true

Exposure time: 70s

ChIC/CUT&RUN sequencing - Anti-Nanog antibody [EPR20694] - ChIP Grade (AB214549)
  • ChIC/CUT&RUN-seq

Supplier Data

ChIC/CUT&RUN sequencing - Anti-Nanog antibody [EPR20694] - ChIP Grade (AB214549)

ChIC/CUT&RUN was performed using a pAG-MNAse at a final concentration of 700 ng/mL, 2.5 x 10^5 F9 (Mouse embryonic testicular cancer cell line) cells and 5µg of ab214549 [EPR20694]. The resulting DNA was sequenced on the Illumina NovaSeq 6000 to a depth of 10 million reads. The negative IgG control ab172730 is also shown. Additional screenshots of mapped reads can be found in the Protocol booklet in the Product Protocol section. The University of Geneva owns patents relevant to ChIC (Chromatin Immuno-Cleavage) methods.

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR20694

Isotype

IgG

Carrier free

No

Reacts with

Mouse

Applications

ChIP, Flow Cyt (Intra), WB, ICC/IF, IP, IHC-P, ChIC/CUT&RUN-seq

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "ChICCUTRUNseq" : {"fullname" : "ChIC/CUT&RUN sequencing", "shortname":"ChIC/CUT&RUN-seq"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "ChIP" : {"fullname" : "ChIP", "shortname":"ChIP"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "FlowCytIntra" : {"fullname" : "Flow Cytometry (Intracellular)", "shortname":"Flow Cyt (Intra)"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Mouse": { "ChICCUTRUNseq-species-checked": "testedAndGuaranteed", "ChICCUTRUNseq-species-dilution-info": "5 µg", "ChICCUTRUNseq-species-notes": "<p></p>", "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "1/30", "IP-species-notes": "<p></p>", "ChIP-species-checked": "testedAndGuaranteed", "ChIP-species-dilution-info": "5 µg for 25 µg chromatin", "ChIP-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1/100", "ICCIF-species-notes": "<p></p>", "FlowCytIntra-species-checked": "testedAndGuaranteed", "FlowCytIntra-species-dilution-info": "1/60", "FlowCytIntra-species-notes": "<p></p>", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/500", "IHCP-species-notes": "<p></p>" } } }

Product details

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Nanog also known as Nanog homeobox is a transcription factor playing an important role in maintaining the pluripotency of embryonic stem cells. The molecular weight of Nanog is approximately 35 kDa. It is found mainly in the inner cell mass of the blastocyst but it also expresses in embryonic stem cells and some adult stem cell populations. Nanog acts by binding to DNA in a sequence-specific manner to regulate gene expression essential for stem cell self-renewal and pluripotency.
Biological function summary

Nanog plays a central role in stem cell biology operating as part of a complex regulatory network. Nanog interacts with other important transcription factors like Oct4 and Sox2 forming a core pluripotency network. This network suppresses the differentiation of stem cells by regulating the expression of genes involved in cell fate decisions. By modulating the expression of different pathways Nanog ensures the maintenance of an undifferentiated state in stem cells.

Pathways

Nanog is deeply embedded in the Wnt/β-Catenin and TGF-β signaling pathways important for stem cell maintenance and differentiation. In the Wnt/β-Catenin pathway Nanog works alongside proteins like β-catenin to drive the expression of genes that promote self-renewal. Meanwhile in the TGF-β pathway Nanog acts with proteins such as Smad2/3 to balance pluripotency and differentiation signals. These pathways critically support the complex network that sustains stem cell identity and function.

Nanog's expression relates closely to its role in various cancers such as glioblastoma and colorectal cancer. Abnormally high levels of Nanog contribute to the tumorigenicity of cancer cells by maintaining their self-renewal and undifferentiated state similar to its role in stem cells. Nanog interacts with proteins like p53 known for its tumor suppressor functions often leading to challenges in cancer treatment. Understanding Nanog's influence in these pathways provides valuable insights into therapeutic targets for combating cancer stem cell resilience.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Transcription regulator involved in inner cell mass and embryonic stem (ES) cells proliferation and self-renewal (PubMed : 25825768). Imposes pluripotency on ES cells and prevents their differentiation towards extraembryonic endoderm and trophectoderm lineages. Blocks bone morphogenetic protein-induced mesoderm differentiation of ES cells by physically interacting with SMAD1 and interfering with the recruitment of coactivators to the active SMAD transcriptional complexes. Acts as a transcriptional activator or repressor. Binds optimally to the DNA consensus sequence 5'-TAAT[GT][GT]-3' or 5'-[CG][GA][CG]C[GC]ATTAN[GC]-3'. Binds to the POU5F1/OCT4 promoter (By similarity). Able to autorepress its expression in differentiating (ES) cells : binds to its own promoter following interaction with ZNF281/ZFP281, leading to recruitment of the NuRD complex and subsequent repression of expression. When overexpressed, promotes cells to enter into S phase and proliferation.
See full target information Nanog

Publications (17)

Recent publications for all applications. Explore the full list and refine your search

Cell biology and toxicology 41:117 PubMed40670831

2025

ZMIZ1 lactylation induces tamoxifen resistance in breast cancer through increasing transcriptional activity of Nanog to impact cell stemness and cholesterol uptake.

Applications

Unspecified application

Species

Unspecified reactive species

Yue Liu,Jingyu Chen,Li Ma,Shu Zhao,Xue Hui,Wenjing Xiong,Shaoqiang Cheng,Yue Zhang

Materials today. Bio 32:101700 PubMed40225139

2025

Engineering a dynamic extracellular matrix using thrombospondin-1 to propel hepatocyte organoids reprogramming and improve mouse liver regeneration post-transplantation.

Applications

Unspecified application

Species

Unspecified reactive species

Zi-Yan Xu,Min Wang,Jing-Yan Shi,Ye Liu,Chao Yu,Xin-Yi Zhang,Chen-Wei Zhang,Qi-Feng He,Chao Pan,Jin Zhou,Hua Xiao,Hong-Yong Cao,Yong Ma

EMBO reports 25:4433-4464 PubMed39256596

2024

Terminal α1,2-fucosylation of glycosphingolipids by FUT1 is a key regulator in early cell-fate decisions.

Applications

Unspecified application

Species

Unspecified reactive species

Saray Chen,Dana Hayoun-Neeman,Michal Nagar,Sapir Pinyan,Limor Hadad,Liat Yaacobov,Lilach Alon,Liraz Efrat Shachar,Tair Swissa,Olga Kryukov,Orly Gershoni-Yahalom,Benyamin Rosental,Smadar Cohen,Rachel G Lichtenstein

Nature communications 15:6200 PubMed39043686

2024

Engineering mouse cell fate controller by rational design.

Applications

Unspecified application

Species

Unspecified reactive species

Tao Huang,Dong Liu,Xiaomin Wang,Junqi Kuang,Manqi Wu,Beibei Wang,Zechuan Liang,Yixin Fan,Bo Chen,Zhaoyi Ma,Yu Fu,Wenhui Zhang,Jin Ming,Yue Qin,Chengchen Zhao,Bo Wang,Duanqing Pei

Biomedicines 12: PubMed38397874

2024

Differential Expression of NOTCH-1 and Its Molecular Targets in Response to Metronomic Followed by Conventional Therapy in a Patient with Advanced Triple-Negative Breast Cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Alice Ilari,Viola Cogliati,Noorhan Sherif,Emanuela Grassilli,Daniele Ramazzotti,Nicoletta Cordani,Giorgio Cazzaniga,Camillo Di Bella,Marialuisa Lavitrano,Marina Elena Cazzaniga,Maria Grazia Cerrito

Nature communications 15:1256 PubMed38341436

2024

Dynamic nucleolar phase separation influenced by non-canonical function of LIN28A instructs pluripotent stem cell fate decisions.

Applications

Unspecified application

Species

Unspecified reactive species

Tianyu Tan,Bo Gao,Hua Yu,Hongru Pan,Zhen Sun,Anhua Lei,Li Zhang,Hengxing Lu,Hao Wu,George Q Daley,Yu Feng,Jin Zhang

Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 52:216-225 PubMed36661031

2023

lncRNA HOXA11-AS maintains the stemness of oral squamous cell carcinoma stem cells and reduces the radiosensitivity by targeting miR-518a-3p/PDK1.

Applications

Unspecified application

Species

Unspecified reactive species

Baojun Li,Yuanjing Lv,Cui Zhang,Cheng Xiang

Stem cells (Dayton, Ohio) 41:354-367 PubMed36715298

2023

FAM122A Is Required for Mesendodermal and Cardiac Differentiation of Embryonic Stem Cells.

Applications

Unspecified application

Species

Unspecified reactive species

Yun-Sheng Yang,Man-Hua Liu,Zhao-Wen Yan,Guo-Qiang Chen,Ying Huang

Neoplasma 69:1406-1417 PubMed36591804

2023

LncRNA CBR3-AS1 predicts a poor prognosis and promotes cervical cancer progression through the miR-3163/LASP1 pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Yipin Cai,Yu Huang,Jie Zhang,Xiaoli Liu,Fang Zhao,Kuan Zhang,Songyuan Xu,Yan Yang,Haiwei Huang,Yu Gao

Advanced healthcare materials 12:e2202401 PubMed36453668

2022

One-Step Preparation of an Injectable Hydrogel Scaffold System Capable of Sequential Dual-Growth Factor Release to Maximize Bone Regeneration.

Applications

Unspecified application

Species

Unspecified reactive species

Jun Kim,Young-Min Kim,Soo-Chang Song
View all publications
chicCutRunSequencingBooklet
en

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com